Cysts Clinical Trial
— DETECTIONOfficial title:
How to Differentiate and Treat Cystic Laesions in the Anterior Mediastinum (DETECTION)
| Verified date | April 2023 |
| Source | Maastricht University Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational [Patient Registry] |
Multicenter trial about anterior mediastinal cysts
| Status | Recruiting |
| Enrollment | 200 |
| Est. completion date | December 1, 2024 |
| Est. primary completion date | December 1, 2024 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: cysts in the anterior mediastinum - Thymic cysts - Bronchogenic cysts - Pericardial cysts - Cystic thymoma - Cystic teratoma Exclusion Criteria: - Patients <18 years old - Patients without radiological imaging - Patients without approval for follow-up |
| Country | Name | City | State |
|---|---|---|---|
| Netherlands | Maastricht UMC | Maastricht | Limburg |
| Lead Sponsor | Collaborator |
|---|---|
| Maastricht University Medical Center | Erasmus Medical Center, The Netherlands Cancer Institute |
Netherlands,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Percentage correctly diagnosed cystic laesions | 2000-2022 | ||
| Secondary | Patient characteristics, complications, comborbidities | 2000-2022 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00280514 -
Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration
|
Phase 4 | |
| Completed |
NCT01087060 -
Detection of Renal Malignancy of Complicated Renal Cysts
|
N/A | |
| Completed |
NCT00001912 -
Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
|
N/A |